Monopar Therapeutics MNPR
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 65.30 | 118.34 | -0.64 | -6,155 | -5 | |
| 2025Q3 | 81.67 | 119.05 | -0.48 | -4,093 | -3 | |
| 2025Q2 | 35.78 | 131.84 | -0.35 | -3,234 | -2 | |
| 2025Q1 | 36.41 | 122.74 | -0.38 | -3,222 | -3 | |
| 2024Q4 | 22.00 | 101.36 | -2.75 | -11,075 | -11 | |
| 2024Q3 | 6.74 | 120.78 | -0.36 | -1,575 | -1 | |
| 2024Q2 | 3.65 | 104.25 | -0.49 | -1,789 | -2 | |
| 2024Q1 | 3.41 | 105.00 | -0.51 | -1,723 | -2 | |
| 2023Q4 | 1.70 | 105.40 | -0.61 | -1,912 | -2 | |
| 2023Q3 | 3.10 | 105.73 | -0.68 | -2,066 | -2 | |
| 2023Q2 | 4.28 | 105.82 | -0.80 | -2,328 | -2 | |
| 2023Q1 | 6.95 | 103.70 | -0.95 | -2,525 | -2 | |
| 2022Q4 | 11.85 | 100.45 | -1.15 | -2,909 | -3 | |
| 2022Q3 | 7.60 | 100.33 | -0.95 | -2,407 | -2 | |
| 2022Q2 | 11.50 | -1.10 | -2,763 | -3 | ||
| 2022Q1 | 12.75 | -0.95 | -2,457 | -2 | ||
| 2021Q4 | 16.05 | 100.04 | -1.05 | -2,681 | -3 | |
| 2021Q3 | 24.35 | 100.04 | -1.00 | -2,459 | -2 | |
| 2021Q2 | 29.45 | 100.58 | -0.80 | -2,092 | -2 | |
| 2021Q1 | 31.00 | 100.58 | -0.80 | -1,895 | -2 |